Kontrastmittel-Nephropathie - Dialyse-oldenburg.de

111. Kurnik BR, Allgren RL, Genter FC et al. Prospective study of atrial natriuretic peptide for
the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674-680.
112. Landoni G, Biondi-Zoccai GG, Marino G: Fenoldopam reduces the need for renal
replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J
Cardiothorac Vasc Anesth 2008; 22:27-33.
113. Stone GW, McCullough PA, Tumlin JA et al. Fenoldopam mesylate for the prevention of
contrast-induced nephropathy: a randomized controlled trial. JAMA 2003; 290: 2284-2291.
114. Briguori C, Colombo A. Airoldi F et al. N-acetylcysteine versus fenoldopam mesylate to
prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004; 44: 762-765.
115. Solomon R. Contrast media nephropathy – how to diagnose and how to prevent? Nephrol
Dial Transplant 2007; 22:1812-1815.
116. Wang A, Holcslaw T, Bashore TM et al. Exacerbation of radiocontrast nephrotoxicity by
endothelin receptor antagonism. Kidney Int 2000, 57: 1675-1680.
117. Koch JA, Plum J, Grabensee B, Modder U. Prostaglandin E1: a new agent for the
prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrol
Dial Transplant 2000; 15: 43-49.
118. Gurkowski L, MacDougall M, Wiegmann T. Effects of misoprostol on contrast-induced
renal dysfunction. Am J Ther 1995; 2: 837-842.
119. Patti G, Nusca A, Chello M, et al.: Usefulness of statin pretreatment to prevent contrastinduced
nephropathy and to improve long-term outcome in patients undergoing percutaneous
coronary intervention. AmJ Cardio12008;101 :279-285.
120. Attalah S, Yassine I, Musial J, et al.: The potential role of statins in contrast nephropathy.
Clin Nephrol 2004; 62: 273-278.
121. Khanal S, Attalah N, Smith DE, et al.: Statin therapy reduces contrast-induced
nephropathy: an analysis of contemporary percutaneous interventions. AmJ Med
2005;118:843-849.
122. Barrett BJ, Parfrey PS: Preventing nephropathy induced by contrast medium. N Engl J
Med 2006; 354:379-386.
123. Hörl WH. Kontrastmittel-induzierte Nephropathie. Spektrum Nephrol 21 (5), 2008: 10-20.
124. EI-Hajjar M, Bashir I, Khan M, et al.: Incidence of contrast-induced nephropathy in
patients with chronic renal insufficiency undergoing multidetector computed tomographic
angiography treated with preventive measures. Am J Cardiol 2008; 102:353-356.
125. Stevens MA, McCullough PA, Tobin KJ et al. A prospective randomized trial of prevention
measures in patients at high risk for contrast nephropathy: results of the PRINCE study. J Am
Coll Cardiol 1999; 33: 403-411.
126. McCulough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51 :1419-
1428.